Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more Biosimilars: Herzuma launched in Europe, FDA rejects Sandoz rituximab. Mundipharm has launched Herzuma, its biosimilar version of Roche’s Herceptin trastuzumab in Europe. ... This follows hot on the heels of MSD (working with Samsung Bioepsis) that

CHMP backs first-line use for AZ’s Tagrisso in lung cancer

CHMP backs first-line use for AZ’s Tagrisso in lung cancer alongside its older HER2 drug Herceptin (trastuzumab). ... The company is positioning Perjeta as a successor to HER2 stalwart Herceptin - which is starting to feel the effects of biosimilar competition - and approval for adjuvant use is another step

Ocrevus helps Roche stave off biosimilar threat

Ocrevus helps Roche stave off biosimilar threat stable sales for cancer antibodies Herceptin (trastuzumab) and Avastin (bevacizumab) - has given Roche the confidence to raise its annual sales and earnings forecasts for 2018. ... The accelerating decline reveals Roche’s vulnerability as biosimilars

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more from blockbusters Avastin, Herceptin and Mabthera/Rituxan.

ViiV’s two-drug HIV combo backed by CHMP

ViiV’s two-drug HIV combo backed by CHMP CHMP meeting round-up. Among other highlights the CHMP backed two biosimilar medicines - Amgen’s Kanjinti version of Roche’s Herceptin (trastuzumab) for the treatment of breast and gastric cancer and

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics